Skip to main content
SpringerLink
Log in

Nontoxic Goiter

  • Living reference work entry
  • First Online:
Thyroid Diseases

Part of the book series: Endocrinology ((ENDOCR))

  • 1529 Accesses

Abstract

Nontoxic goiter is a common condition related to deficiency in the iodine intake. Other etiological factors include genetic susceptibility, female gender, age, and tobacco smoking. Since the thyroid tissue has preponderance for nodular degeneration, most goiters harbor nodules of different size and texture. In some patients with long-standing goiter, hyperthyroidism will emerge gradually due to functional autonomy of one or more nodules. Although the risk of malignancy in nodular goiter is low in unselected patients, evaluation by thyroid ultrasonography, and by fine-needle aspiration biopsy of nodules with suspicious features, is crucial for determining the nature of the goiter.

In reaching a treatment decision, a range of factors should be taken into account. Asymptomatic patients with a benign goiter most often need no treatment. Thyroid surgery, typically in the form of a hemi- or a total thyroidectomy, can rapidly remove the target tissue and is the treatment of choice if the goiter is very large, if it compromises the upper airways, or if there is suspicion of thyroid malignancy. Specific risks, correlating with goiter size, include vocal cord paralysis and hypoparathyroidism, and these risks increase in cases of reoperation for recurrent goiter.

The noninvasive nature is the major advantage of radioiodine (131I) therapy, resulting in a goiter volume reduction of 35–50% within 2 years. However, a low thyroid 131I uptake (RAIU) is a hindrance for 131I therapy efficacy in some patients. In such cases, recombinant human TSH (rhTSH) stimulation can augment the goiter shrinkage, which reduces the need for additional treatment due to goiter recurrence. Alternatively, rhTSH stimulation allows a reduction of the administered 131I, while achieving a goiter reduction comparable to that obtained by 131I therapy given without rhTSH stimulation.

In selected patients, noninvasive interventional treatment may be an option in solitary thyroid lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Reference

  • Abdel Rahim AA, Ahmed ME, Hassan MA. Respiratory complications after thyroidectomy and the need for tracheostomy in patients with a large goitre. Br J Surg. 1999;86:88–90.

    Article  CAS  PubMed  Google Scholar 

  • Abdul-Sater L, Henry M, Majdan A, et al. What are thyroidectomy patients really concerned about? Otolaryngol Head Neck Surg. 2011;144:685–90.

    Article  PubMed  Google Scholar 

  • Abrahamsen B, Jorgensen HL, Laulund AS, et al. Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort. J Bone Miner Res. 2014;29:2040–50.

    Article  CAS  PubMed  Google Scholar 

  • Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab. 1999;84:561–6.

    CAS  PubMed  Google Scholar 

  • Albareda M, Viguera J, Santiveri C, et al. Upper airway obstruction in patients with endothoracic goiter enlargement: no relationship between flow-volume loops and radiological tests. Eur J Endocrinol. 2010;163:665–9.

    Article  CAS  PubMed  Google Scholar 

  • Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:593–646.

    Article  CAS  Google Scholar 

  • Baloch ZW, LiVolsi VA. Current role and value of fine-needle aspiration in nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:531–44.

    Article  PubMed  Google Scholar 

  • Berg G, Jacobsson L, Nystrom E, et al. Consequences of inadvertent radioiodine treatment of Graves’ disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing? Acta Oncol. 2008;47:145–9.

    Article  CAS  PubMed  Google Scholar 

  • Berghout A, Wiersinga WM, Drexhage HA, et al. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet. 1990;336:193–7.

    Article  CAS  PubMed  Google Scholar 

  • Bogazzi F, Tomisti L, Ceccarelli C, et al. Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note. Clin Endocrinol. 2010;72:133–4.

    Article  CAS  Google Scholar 

  • Bone SL, Vertigan AE, Eisenberg RL. Auditory-perceptual voice characteristics in pre-operative patients undergoing thyroid or parathyroid surgery. Folia Phoniatr Logop. 2012;64:87–93.

    Article  PubMed  Google Scholar 

  • Bonnema SJ. Upper airway obstruction due to goiter: an overlooked problem! J Postgrad Med. 2008;54:82–3.

    Article  CAS  PubMed  Google Scholar 

  • Bonnema SJ, Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012;33:920–80.

    Article  CAS  PubMed  Google Scholar 

  • Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab. 1999;84:3636–41.

    CAS  PubMed  Google Scholar 

  • Bonnema SJ, Bennedbæk FN, Wiersinga WM, et al. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol. 2000;53:5–12.

    Article  CAS  Google Scholar 

  • Bonnema SJ, Andersen PB, Knudsen DU, et al. MR imaging of large multinodular goiters: Observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol. 2002a;179:259–66.

    Article  PubMed  Google Scholar 

  • Bonnema SJ, Knudsen DU, Bertelsen H, et al. Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Thyroid. 2002b;12:313–7.

    Article  PubMed  Google Scholar 

  • Bonnema SJ, Nielsen VE, Hegedüs L. Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. Eur J Endocrinol. 2004;150:439–45.

    Article  CAS  PubMed  Google Scholar 

  • Bonnema SJ, Nielsen VE, Boel-Jørgensen H, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab. 2007;92:3424–8.

    Article  CAS  PubMed  Google Scholar 

  • Bonnema SJ, Nielsen VE, Boel-Jørgensen H, et al. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. J Clin Endocrinol Metab. 2008;93:3981–4.

    Article  CAS  PubMed  Google Scholar 

  • Brandt F, Almind D, Christensen K, et al. Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab. 2012;97:4123–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brandt F, Thvilum M, Almind D, et al. Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One. 2013a;8:e66711.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brandt F, Thvilum M, Almind D, et al. Graves’ disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid. 2013b;23:408–13.

    Article  PubMed  Google Scholar 

  • Braverman L, Kloos RT, Law Jr B, et al. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. Endocr Pract. 2008;14:832–9.

    Article  PubMed  Google Scholar 

  • Brito JP, Gionfriddo MR, Al NA, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99:1253–63.

    Article  CAS  PubMed  Google Scholar 

  • Brix TH, Kyvik KO, Hegedüs L. Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab. 1999;84:3071–5.

    CAS  PubMed  Google Scholar 

  • Brix TH, Hansen PS, Kyvik KO, et al. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 2000;160:661–6.

    Article  CAS  PubMed  Google Scholar 

  • Burikhanov RB, Matsuzaki S. Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo. Thyroid. 2000;10:123–9.

    Article  CAS  PubMed  Google Scholar 

  • Campanella P, Ianni F, Rota CA, et al. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014;170:R203–11.

    Article  CAS  PubMed  Google Scholar 

  • Carle A, Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab. 2014;28:465–79.

    Article  CAS  PubMed  Google Scholar 

  • Ceccarelli C, Canale D, Battisti P, et al. Testicular function after 131I therapy for hyperthyroidism. Clin Endocrinol. 2006;65:446–52.

    Article  CAS  Google Scholar 

  • Choi SH, Kim EK, Kwak JY, et al. Interobserver and intraobserver variations in ultrasound assessment of thyroid nodules. Thyroid. 2010;20:167–72.

    Article  PubMed  Google Scholar 

  • Cramon P, Bonnema SJ, Bjorner JB, et al. Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population. Thyroid. 2015;25:284–91.

    Article  PubMed  Google Scholar 

  • Dralle H, Machens A, Thanh PN. Minimally invasive compared with conventional thyroidectomy for nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:589–99.

    Article  PubMed  Google Scholar 

  • Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999;140:3404–10.

    Article  CAS  PubMed  Google Scholar 

  • Eszlinger M, Hegedus L, Paschke R. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2014;28:545–57.

    Article  CAS  PubMed  Google Scholar 

  • Fast S, Bonnema SJ, Hegedüs L. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy. Clin Endocrinol. 2008;69:653–8.

    Article  Google Scholar 

  • Fast S, Nielsen VE, Bonnema SJ, et al. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol. 2009a;160:517–28.

    Article  CAS  PubMed  Google Scholar 

  • Fast S, Nielsen VE, Grupe P, et al. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med. 2009b;50:732–7.

    Article  CAS  PubMed  Google Scholar 

  • Fast S, Hegedüs L, Grupe P, et al. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab. 2010a;95:3719–25.

    Article  CAS  PubMed  Google Scholar 

  • Fast S, Nielsen VE, Bonnema SJ, et al. Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0.1, 0.3 and 0.9 mg of rhTSH. Clin Endocrinol. 2010b;72:411–6.

    Article  CAS  Google Scholar 

  • Fast S, Nielsen VE, Grupe P, et al. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. J Clin Endocrinol Metab. 2012;97:2653–60.

    Article  CAS  PubMed  Google Scholar 

  • Fiore E, Tonacchera M, Vitti P. Influence of iodization programmes on the epidemiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:577–88.

    Article  PubMed  Google Scholar 

  • Fiorentino E, Cipolla C, Graceffa G, et al. Local neck symptoms before and after thyroidectomy: a possible correlation with reflux laryngopharyngitis. Eur Arch Otorhinolaryngol. 2011;268:715–20.

    Article  PubMed  Google Scholar 

  • Franklyn JA, Maisonneuve P, Sheppard MC, et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998;338:712–8.

    Article  CAS  PubMed  Google Scholar 

  • Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA. 2005;294:71–80.

    Article  CAS  PubMed  Google Scholar 

  • Garsi JP, Schlumberger M, Rubino C, et al. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med. 2008;49:845–52.

    Article  PubMed  Google Scholar 

  • Gharib H, Hegedus L, Pacella CM, et al. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98:3949–57.

    Article  CAS  PubMed  Google Scholar 

  • Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules – 2016 Update. Endocr Pract. 2016;22:622–39.

    Article  PubMed  Google Scholar 

  • Giovanella L, Ceriani L, Treglia G. Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:507–18.

    Article  PubMed  Google Scholar 

  • Glinoer D, Verelst J, Ham HR. Abnormalities of esophageal transit in patients with sporadic nontoxic goitre. Eur J Nucl Med. 1987;13:239–43.

    Article  CAS  PubMed  Google Scholar 

  • Graf H, Fast S, Pacini F, et al. Modified-release recombinant human TSH (MRrhTSH) augments the effect of 131I therapy in benign multinodular goiter. Results from a multicenter international, randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011;96:1368–76.

    Article  CAS  PubMed  Google Scholar 

  • Grussendorf M, Reiners C, Paschke R, et al. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2011;96:2786–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hamdan AL, Dowli A, Jabbour J, et al. Phonatory symptoms and impact on quality of life in female patients with goiter. Ear Nose Throat J. 2016;95:E5–E10.

    PubMed  Google Scholar 

  • Hansen PS, Brix TH, Sorensen TI, et al. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy danish twins. J Clin Endocrinol Metab. 2004;89:1181–7.

    Article  CAS  PubMed  Google Scholar 

  • Hasselgren M, Hegedus L, Godballe C, et al. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules. Head Neck. 2010;32:612–8.

    PubMed  Google Scholar 

  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  • Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008;93:809–14.

    Article  CAS  PubMed  Google Scholar 

  • Hegedüs L. Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease (thesis). Dan Med Bull. 1990;37:249–63.

    PubMed  Google Scholar 

  • Hegedüs L. Thyroid ultrasound. Endocrinol Metab Clin N Am. 2001;30:339–60.

    Article  Google Scholar 

  • Hegedüs L, Bonnema SJ. Approach to management of the patient with primary or secondary intrathoracic goiter. J Clin Endocrinol Metab. 2010;95:5155–62.

    Article  PubMed  CAS  Google Scholar 

  • Hegedüs L, Rasmussen N, Ravn V, et al. Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism. 1988;37:229–33.

    Article  PubMed  Google Scholar 

  • Hegedüs L, Nygaard B, Hansen JM. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab. 1999;84:756–60.

    PubMed  Google Scholar 

  • Hegedüs L, Bonnema SJ, Bennedbæk FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24:102–32.

    Article  PubMed  Google Scholar 

  • Hegedüs L, Brix TH, Paschke R. Etiology of simple goiter. Thyroid. 2009;19:209–11.

    Article  PubMed  Google Scholar 

  • Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94:1748–51.

    Article  CAS  PubMed  Google Scholar 

  • Huysmans DA, Hermus AR, Corstens FH, et al. Large, compressive goiters treated with radioiodine. Ann Intern Med. 1994;121:757–62.

    Article  CAS  PubMed  Google Scholar 

  • Hyer S, Vini L, O’Connell M, et al. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol. 2002;56:755–8.

    Article  CAS  Google Scholar 

  • Jarhult J, Vedad R. A conservative approach is reasonable in patients with non-toxic goitre: results from an observational study during 30 years. Eur Thyroid J. 2014;3:240–4.

    PubMed  PubMed Central  Google Scholar 

  • Jarløv AE, Hegedüs L, Gjørup T, et al. Observer variation in the clinical assessment of the thyroid gland. J Intern Med. 1991;229:159–61.

    Article  PubMed  Google Scholar 

  • Jauregui R, Lilker ES, Bayley A. Upper airway obstruction in euthyroid goiter. JAMA. 1977;238:2163–6.

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen F, Hesse B, Gronbaek P, et al. Abnormal oesophageal function in patients with non-toxic goiter or enlarged left atrium, demonstrated by radionuclide transit measurements. Scand J Gastroenterol. 1989;24:1186–92.

    Article  CAS  PubMed  Google Scholar 

  • Kahaly G, Dienes HP, Beyer J, et al. Randomized, double blind, placebo-controlled trial of low dose iodide in endemic goiter. J Clin Endocrinol Metab. 1997;82:4049–53.

    Article  CAS  PubMed  Google Scholar 

  • Knudsen N, Brix TH. Genetic and non-iodine-related factors in the aetiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:495–506.

    Article  CAS  PubMed  Google Scholar 

  • Knudsen N, Bülow I, Jørgensen T, et al. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol. 2000;53:479–85.

    Article  CAS  Google Scholar 

  • Knudsen N, Bülow I, Laurberg P, et al. Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol. 2001;55:41–6.

    Article  CAS  Google Scholar 

  • Knudsen N, Bulow I, Laurberg P, et al. Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol. 2002;57:71–6.

    Article  CAS  Google Scholar 

  • Kornelius E, Chiou JY, Yang YS, et al. Iodinated contrast media-induced thyroid dysfunction in euthyroid nodular goiter patients. Thyroid. 2016;26:1030–8.

    Article  CAS  PubMed  Google Scholar 

  • Krejbjerg A, Bjergved L, Pedersen IB, et al. Thyroid nodules in an 11-year DanThyr follow-up study. J Clin Endocrinol Metab. 2014;99:4749–57.

    Article  CAS  PubMed  Google Scholar 

  • Lang BH, Chu KK, Tsang RK, et al. Evaluating the incidence, clinical significance and predictors for vocal cord palsy and incidental laryngopharyngeal conditions before elective thyroidectomy: is there a case for routine laryngoscopic examination? World J Surg. 2014;38:385–91.

    Article  PubMed  Google Scholar 

  • Laulund AS, Nybo M, Brix TH, et al. Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort. PLoS One. 2014;9:e110437.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Laurberg P, Jorgensen T, Perrild H, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006;155:219–28.

    Article  CAS  PubMed  Google Scholar 

  • Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4:933–42.

    Article  PubMed  Google Scholar 

  • Lee S, Skelton TS, Zheng F, et al. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013;217:81–8.

    Article  PubMed  Google Scholar 

  • Melissant CF, Smith SJ, Perlberger R, et al. Lung function, CT-scan and X-ray in upper airway obstruction due to thyroid goitre. Eur Respir J. 1994;7:1782–7.

    Article  CAS  PubMed  Google Scholar 

  • Menon SK, Jagtap VS, Sarathi V, et al. Prevalence of upper airway obstruction in patients with apparently asymptomatic euthyroid multi nodular goitre. Indian J Endocrinol Metab. 2011;15:S127–31.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Metso S, Jaatinen P, Huhtala H, et al. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab. 2007;92:2190–6.

    Article  CAS  PubMed  Google Scholar 

  • Metso S, Auvinen A, Salmi J, et al. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol. 2008;68:450–7.

    Google Scholar 

  • Miller MR, Pincock AC, Oates GD, et al. Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med. 1990;74:177–88.

    CAS  PubMed  Google Scholar 

  • Na DG, Baek JH, Sung JY, et al. Thyroid imaging reporting and data system risk stratification of thyroid nodules: categorization based on solidity and echogenicity. Thyroid. 2016;26:562–72.

    Article  PubMed  Google Scholar 

  • Netterville JL, Coleman SC, Smith JC, et al. Management of substernal goiter. Laryngoscope. 1998;108:1611–7.

    Article  CAS  PubMed  Google Scholar 

  • Nielsen VE, Bonnema SJ, Boel-Jørgensen H, et al. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab. 2005;90:79–83.

    Article  CAS  PubMed  Google Scholar 

  • Nielsen VE, Bonnema SJ, Boel-Jørgensen H, et al. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med. 2006;166:1476–82.

    Article  CAS  PubMed  Google Scholar 

  • Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, et al. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab. 2001;86:5330–6.

    Article  CAS  PubMed  Google Scholar 

  • Nieuwlaat WA, Huysmans DA, Van Den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab. 2003;88:3121–9.

    Article  CAS  PubMed  Google Scholar 

  • Nieuwlaat WA, Hermus AR, Ross HA, et al. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. J Nucl Med. 2004;45:626–33.

    CAS  PubMed  Google Scholar 

  • Nygaard B, Hegedüs L, Gervil M, et al. Radioiodine treatment of multinodular non-toxic goitre. Br Med J. 1993;307:828–32.

    Article  CAS  Google Scholar 

  • Nygaard B, Hegedüs L, Gervil M, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves’ disease. J Intern Med. 1995;238:491–7.

    Article  CAS  PubMed  Google Scholar 

  • Nygaard B, Hegedüs L, Ulriksen P, et al. Radioiodine therapy for multinodular toxic goiter. Arch Intern Med. 1999a;159:1364–8.

    Article  CAS  PubMed  Google Scholar 

  • Nygaard B, Metcalfe RA, Phipps J, et al. Graves’ disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter. J Endocrinol Investig. 1999b;22:481–5.

    Article  CAS  Google Scholar 

  • Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87:1941–6.

    Article  CAS  PubMed  Google Scholar 

  • Papini E, Pacella CM, Misischi I, et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: towards a patient-tailored approach. Best Pract Res Clin Endocrinol Metab. 2014;28:601–18.

    Article  PubMed  Google Scholar 

  • Pappalardo G, Guadalaxara A, Frattaroli FM, et al. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg. 1998;164:501–6.

    Article  CAS  PubMed  Google Scholar 

  • Pedersen IB, Knudsen N, Perrild H, et al. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves’ disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol. 2001;55:381–90.

    Article  CAS  Google Scholar 

  • Perrild H, Hansen JM, Hegedüs L, et al. Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol. 1982;100:382–7.

    CAS  PubMed  Google Scholar 

  • Rago T, Vitti P. Diagnostic role of ultrasound and elastosonography in nodular goiter. Best Pract Res Clin Endocrinol Metab. 2014;28:519–29.

    Article  PubMed  Google Scholar 

  • Remonti LR, Kramer CK, Leitão CB, et al. Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid. 2015;25:538–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rubio IG, Perone BH, Silva MN, et al. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies. Thyroid. 2005;15:134–9.

    Article  CAS  PubMed  Google Scholar 

  • Russ G, Bonnema SJ, Erdogan MF et al. European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017 (in press).

    Google Scholar 

  • Sawka AM, Lakra DC, Lea J, et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol. 2008a;69:479–90.

    Article  Google Scholar 

  • Sawka AM, Lea J, Alshehri B, et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol. 2008b;68:610–7.

    Article  Google Scholar 

  • Scerrino G, Inviati A, Di GS, et al. Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results. Otolaryngol Head Neck Surg. 2013;148:926–32.

    Article  PubMed  Google Scholar 

  • Singh ON, Maraka S, Espinosa DA, et al. Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis. Clin Endocrinol. 2016;85:122–31.

    Article  Google Scholar 

  • Smith TJ, Hegedus L. Graves’ disease. N Engl J Med. 2016;375:1552–65.

    Article  PubMed  Google Scholar 

  • Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid. 2012;22:918–25.

    Article  CAS  PubMed  Google Scholar 

  • Sørensen JR, Hegedus L, Kruse-Andersen S, et al. The impact of goitre and its treatment on the trachea, airflow, oesophagus and swallowing function. A systematic review. Best Pract Res Clin Endocrinol Metab. 2014;28:481–94.

    Article  PubMed  Google Scholar 

  • al Suliman NN, Ryttov NF, Qvist N, et al. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg. 1997;163:13–20.

    Google Scholar 

  • Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–38.

    Article  CAS  PubMed  Google Scholar 

  • Swan KZ, Nielsen VE, Bibby BM et al. Is the reproducibility of shear wave elastography of thyroid nodules high enough for clinical use? A methodological study. Clin Endocrinol (Oxf). 2016. doi: 10.1111/cen.13295. [Epub ahead of print]

    Google Scholar 

  • Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226–31.

    Article  CAS  PubMed  Google Scholar 

  • Tan GH, Gharib H, Reading CC. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med. 1995;155:2418–23.

    Article  CAS  PubMed  Google Scholar 

  • Thusoo TK, Gupta U, Kochhar K, et al. Upper airway obstruction in patients with goiter studies by flow volume loops and effect of thyroidectomy. World J Surg. 2000;24:1570–2.

    Article  CAS  PubMed  Google Scholar 

  • Torchio R, Gulotta C, Perboni A, et al. Orthopnea and tidal expiratory flow limitation in patients with euthyroid goiter. Chest. 2003;124:133–40.

    Article  PubMed  Google Scholar 

  • Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55–68.

    Article  CAS  Google Scholar 

  • Vejbjerg P, Knudsen N, Perrild H, et al. Effect of a mandatory iodization program on thyroid gland volume based on individuals’ age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study. J Clin Endocrinol Metab. 2007;92:1397–401.

    Article  CAS  PubMed  Google Scholar 

  • Verloop H, Louwerens M, Schoones JW, et al. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97:2243–55.

    Article  CAS  PubMed  Google Scholar 

  • Wallace C, Siminoski K. The Pemberton sign. Ann Intern Med. 1996;125:568–9.

    Article  CAS  PubMed  Google Scholar 

  • Watt T, Grønvold M, Rasmussen AK, et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol. 2006;154:501–10.

    Article  CAS  PubMed  Google Scholar 

  • Watt T, Cramon P, Frendl DM, et al. Assessing health-related quality of life in patients with benign non-toxic goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:559–75.

    Article  PubMed  Google Scholar 

  • Wesche MF, Tiel-Van Buul MM, Lips P, et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab. 2001;86:998–1005.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Odense University Hospital, DK, 5000, Odense, Denmark

    Steen Joop Bonnema & Laszlo Hegedüs

Authors
  1. Steen Joop Bonnema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laszlo Hegedüs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steen Joop Bonnema .

Editor information

Editors and Affiliations

  1. Department of Endocrinology, University of Pisa, Pisa, Italy

    Paolo Vitti

  2. Department of Endocrinology and Metaboli, Odense Univeristy Hospital, Odense, Denmark

    Laszlo Hegedus

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Bonnema, S.J., Hegedüs, L. (2017). Nontoxic Goiter. In: Vitti, P., Hegedus, L. (eds) Thyroid Diseases. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-29195-6_5-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29195-6_5-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29195-6

  • Online ISBN: 978-3-319-29195-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation